BII
XLRN

Bainco International Investors’s Acceleron Pharma XLRN Stock Holding History

Bainco International Investors’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$161K Buy
+1,257
New +$147K 0.02% 80
2020
Q2 		– Sell
-1,257
Closed -$113K – 279
2020
Q1 		$113K Buy
+1,257
New +$97.7K 0.02% 91

Other funds holding XLRN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bainco International Investors's XLRN Position: Q4 2020 in Review

Bainco International Investors opened a new position in Acceleron Pharma (XLRN) in Q4 2020: 1,257 shares worth $161K. The stake represents 0.02% of the portfolio and ranks #80 among its holdings. This is a return to the name: Bainco International Investors previously reported a position in XLRN as recently as Q1 2020.

Bainco International Investors first reported a position in XLRN in Q1 2020 and has held it in 2 quarters since. 253 funds tracked by Wall St. Rank hold XLRN as of Q4 2020.

  • Bainco International Investors held 1,257 shares of Acceleron Pharma worth $161K as of Q4 2020.
  • Acceleron Pharma was a new Bainco International Investors position in Q4 2020.
  • Acceleron Pharma made up 0.02% of Bainco International Investors's portfolio in Q4 2020, its #80 holding.
  • Bainco International Investors first reported a position in Acceleron Pharma in Q1 2020 and has held it in 2 quarters since.
  • 253 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2020.

Based on Bainco International Investors's 13F filing for Q4 2020, filed 12 Jan 2021.